Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Analysis of the symptom response to esomeprazole 20 mg over days 1-4 of a 14-day course of treatment for frequent heartburn: results of two randomised controlled trials.
Journal: BMJ open gastroenterology
Published: January 18, 2019
Egyptian recommendations for management of Helicobacter pylori infection: 2018 report.
Journal: Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology
Published: October 25, 2018
Sustained efficacy following resolution of frequent heartburn with an over-the-counter regimen of esomeprazole 20 mg or placebo for 14 days: two randomized trials.
Journal: BMC gastroenterology
Published: November 16, 2017
A 14-day regimen of esomeprazole 20 mg/day for frequent heartburn: durability of effects, symptomatic rebound, and treatment satisfaction.
Journal: Postgraduate medicine
Published: June 23, 2016
Managing gastroesophageal reflux disease - comparative efficacy and outcomes of dexlansoprazole MR.
Journal: Therapeutics and clinical risk management
Published: November 21, 2015
25 Years of Proton Pump Inhibitors: A Comprehensive Review.
Journal: Gut and liver
Published: October 05, 2015
Esomeprazole treatment of frequent heartburn: two randomized, double-blind, placebo-controlled trials.
Journal: Postgraduate medicine
Published: August 21, 2014
Pharmacodynamic evaluation of intragastric pH and implications for famotidine dosing in the prophylaxis of non-steroidal anti-inflammatory drug induced gastropathy-a proof of concept analysis.
Journal: Journal of drug assessment
Published: January 01, 2014
The use of H2 antagonists in treating and preventing NSAID-induced mucosal damage.
Journal: Arthritis research & therapy
Published: November 26, 2013
Distinguishing the impact of dexlansoprazole on heartburn vs. regurgitation in patients with gastro-oesophageal reflux disease.
Journal: Alimentary pharmacology & therapeutics
Published: April 01, 2013
Budget impact modeling for a single-tablet formulation of ibuprofen and famotidine for prevention of upper gastrointestinal ulcers in patients with osteoarthritis and/or rheumatoid arthritis.
Journal: Clinical therapeutics
Published: November 15, 2012
Last Updated: 09/26/2026